Revenue
-
Net Income
-$57.4M
▼ 28.8% YoY
EPS
$-1.34
▲ 38.2% YoY
Cash
$49.7M
▼ 69.5% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Fry Hannah VP, Controller | Sell tax | Jan 26, 2026 | 1.5K | $6.67 | $10K | Form 4 ↗ |
Fabbio Patrick Chief Financial Officer | Sell tax | Jan 26, 2026 | 3.3K | $6.67 | $22K | Form 4 ↗ |
Shefferman Jesse CEO and President | Sell tax | Jan 26, 2026 | 8.7K | $6.67 | $58K | Form 4 ↗ |
Zummo Jacqueline Chf Scientific Operations Off | Sell tax | Jan 26, 2026 | 3.7K | $6.67 | $25K | Form 4 ↗ |
Shefferman Jesse CEO and President | Sell tax | Jan 20, 2026 | 16.3K | $5.60 | $91K | Form 4 ↗ |
Fabbio Patrick Chief Financial Officer | Sell tax | Jan 20, 2026 | 3.1K | $5.60 | $17K | Form 4 ↗ |
Zummo Jacqueline Chf Scientific Operations Off | Sell tax | Jan 20, 2026 | 6.6K | $5.60 | $37K | Form 4 ↗ |
Fry Hannah VP, Controller | Sell tax | Jan 20, 2026 | 2.1K | $5.60 | $12K | Form 4 ↗ |
CONKLING WILLIAM Chief Commercial Officer | Grant | Jan 16, 2026 | 26.0K | $0.00 | $0 | Form 4 ↗ |
Fabbio Patrick Chief Financial Officer | Grant | Jan 16, 2026 | 28.0K | $0.00 | $0 | Form 4 ↗ |
Fry Hannah VP, Controller | Grant | Jan 16, 2026 | 9.5K | $0.00 | $0 | Form 4 ↗ |
Nicacio Leonardo Viana Chief Medical Officer | Grant | Jan 16, 2026 | 26.0K | $0.00 | $0 | Form 4 ↗ |